Faculty Expert Spotlight

Find research partners among faculty experts and specialized centers and institutes across disciplines—from infectious diseases and emerging pathogens to statistics and biochemistry.

Expert Photo

Ji-Hyun Lee

PH-Pharmacodynamics

UF

Expert Photo

Necibe Tuncer

Department of Mathematical Sci

FAU

Expert Photo

Margaret Fischl

Medicine

UM

Expert Photo

Thayumanasamy Somasundaram

Inst of Molecular Biophysics

FSU

Expert Photo

Esther Guzmán

Marine Biomedical & Biotechnology Research

FAU

Expert Photo

Raid Amin

Mathematics & Statistics

UWF

Expert Photo

Otto Phanstiel

Medical Education

UCF

Expert Photo

Wasim Maziak

Epidemiology

FIU

Expert Photo

Erin Largo-Wight

Public Health

UNF

Expert Photo

Peter Holland

Integrated Medical Science

FAU

Expert Photo

Lyndsay Rhodes

Biological Sciences

FGCU

Expert Photo

Ruisheng Liu

Molecular Pharmacology and Physiology

USF

Centers | Colleges | Departments

Discover leading-edge specialized centers and institutes focusing on COVID-19 and related research, as well as colleges of medicine and public health and departments of infectious diseases.

Research Centers & Institutes

Research Centers & Institutes

Research Centers & Institutes

Colleges of Medicine

Colleges of Medicine

Colleges of Medicine

Departments of Infectious Diseases

Departments of Infectious Diseases

Departments of Infectious Diseases

Colleges of Public Health

Colleges of Public Health

Colleges of Public Health

Research Centers & Institutes

Leading Edge

Emerging Pathogens Institute UF
One Health Center for Excellence UF

Biomolecular Sciences Institute FIU
Burnett School of Biomedical Sciences UCF
Center for Inflammation and Mucosal Immunology UF
Center for Medicine and Public Health FSU
Center for Molecular Biology and Biotechnology FAU
Center for Molecular Delivery USF
Center for Molecular Microbiology UF
Center for Pharmacogenomics and Precision Medicine UF
Center for Pharmacometrics and Systems Pharmacology UF
Center on Global Health FSU
Clinical and Translational Science Institute UF
Florida Prevention Research Center USF
GeoData Center UWF
Global Health & Infectious Diseases Research USF
Global Health Consortium FIU
Institute for Human Health and Disease Intervention (I-Health) FAU
Institute for Therapeutic Innovation UF
Institute of NeuroImmune Pharmacology FIU
x

Research in Action

Check out the university research being highlighted via our Twitter account.

Faculty Research Publications via Pubmed

Access recent journal articles authored by Florida faculty.

Link To PubMed Entry

Transcriptomics reveal immune downregulation of newts overwhelmed by chytrid co-infection.

Mol Ecol. 2020 Aug 03;:

Authors: Shepack A, Catenazzi A

Abstract
What happens when two emergent diseases infect the same host? In a From the Cover article in this issue of Molecular Ecology, McDonald et al. (2020) compare transcriptomic responses to coinfection by the two chytrid fungi in the skin, liver and spleen of Eastern newts (Notophthalmus viridescens). Novel molecular tools, such as high-throughput DNA sequencing for genome discovery and transcriptomics, have revolutionized our understanding of host-pathogen interactions and disease ecology (Güimil et al. 2005; Rosenblum et al. 2012). For example, epidemiologists are using genomic data to track the spread of the emergent SARS-CoV-2 in real time, both locally and globally.

PMID: 32745298 [PubMed - as supplied by publisher]

Link To PubMed Entry

Related Articles

Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2.

bioRxiv. 2020 Jul 24;:

Authors: Banerjee S, Majumder K, Gutierrez GJ, Gupta D, Mittal B

Abstract
The novel Corona Virus Disease (COVID-19) pandemic has spread a blaze of increasing fatality rates across the world. The dearth of potential vaccines has left the survival of mankind with doubts. The development of multi-epitope vaccine in this current situation could be a possible COVID treatment. We have designed a novel multi-epitope, multi-protein vaccine with different proteins of Severe Acute Respiratory Syndrome - Corona Virus -2 (SARS-CoV-2) with immuno-informatics approaches, which has been validated in silico to be stable and potential. It has been prepared with Cytotoxic T-cell (TC) and Helper T-cell (TH) binding epitopes overlapping with B-cell binding epitopes predicted for 6 proteins conserved among 4 different viral strains isolated across the world. Both the humoral and cell-mediated immune responses are ensured due to the presence of T cell and B-cell inducing epitopes along with interferon-gamma inducing epitopes present in the vaccine. The final vaccine construct comprises of an adjuvant at the N terminal, Cytotoxic T Lymphocyte and Helper T Lymphocyte epitopes. The construct showed potential antigenicity and was non-allergic. The molecular docking of the refined, validated tertiary structure model of the vaccine was performed with immune-stimulatory Toll Like Receptors (TLR), TLR-2,3,4. The study of binding energetics of the docked complexes revealed binding interactions of receptor with vaccine. The immune simulation of the vaccine even confirmed the initiation of elevated host immune responses. The efficient translation of the vaccine in an expression vector was confirmed with in silico cloning approach. Certainly, the development of such vaccine candidate could possibly be an effective therapy for COVID-19.

PMID: 32743567 [PubMed]

Link To PubMed Entry

A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.

Asia Pac J Ophthalmol (Phila). 2020 Jul-Aug;9(4):374-375

Authors: Martinez Navarro W, Ly L, Segal MS, Shukla AM

PMID: 32740071 [PubMed - as supplied by publisher]

Link To PubMed Entry

Negative Pressure Airway Management Hood for COVID-19 Patients during Invasive Airway Procedures.

Anesthesiology. 2020 Jul 24;:

Authors: Eslahpazir B, Huang J

PMID: 32739993 [PubMed - as supplied by publisher]

Funding Opportunities | Blogs | Websites

Explore other resources devoted to COVID-19 such as blogs, websites, and lists of funding opportunities.